{"nctId":"NCT01465763","briefTitle":"A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis","startDateStruct":{"date":"2012-04"},"conditions":["Ulcerative Colitis"],"count":614,"armGroups":[{"label":"tofacitinib 10 mg BID","type":"EXPERIMENTAL","interventionNames":["Drug: tofacitinib"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"tofacitinib","otherNames":["CP-690,550"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subject must be at least 18 years of age.\n* Males and females with a documented diagnosis of UC at least 4 months prior to entry into the study.\n* Subjects with moderately to severely active UC based on Mayo score criteria.\n* Subjects must have failed or be intolerant of at least one of the following treatments for UC:\n\n  * Corticosteroids (oral or intravenous).\n  * Azathioprine or 6 mercaptopurine (6 MP).\n  * Anti TNF-alpha therapy.\n\nExclusion Criteria:\n\n* Presence of indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, or clinical findings suggestive of Crohn's disease.\n* Subjects with disease limited to distal 15 cm.\n* Subjects without previous treatment for UC (ie, treatment na√Øve).\n* Subjects displaying clinical signs of fulminant colitis or toxic megacolon.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants With Remission at Week 8","description":"Remission in participants was defined by a total Mayo score of 2 points or lower, with no individual subscore exceeding 1 point and a rectal bleeding subscore of 0. Mayo score is an instrument designed to measure disease activity of ulcerative colitis (UC). It consisted of 4 subscores: stool frequency, rectal bleeding, findings of centrally read flexible proctosigmoidoscopy and physician global assessment (PGA), each graded from 0 to 3 with higher scores indicating more severe disease. These scores were summed up to give a total score range of 0 to 12; where higher scores indicating more severe disease.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.5","spread":null},{"groupId":"OG001","value":"8.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Achieving Mucosal Healing at Week 8","description":"Mucosal healing in participants was defined by Mayo endoscopic subscore of 0 or 1. The Mayo endoscopic subscore consisted of the findings of centrally read flexible proctosigmoidoscopy, graded from 0 to 3 with higher scores indicating more severe disease.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31.3","spread":null},{"groupId":"OG001","value":"15.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Achieving Clinical Response at Week 8","description":"Clinical response in participants was defined by a decrease from baseline in Mayo score of at least 3 points and at least 30 percent, with an accompanying decrease in the rectal bleeding subscore of at least 1 point or an absolute rectal bleeding subscore of 0 or 1. Mayo score is an instrument designed to measure disease activity of UC. It consisted of 4 subscores: stool frequency, rectal bleeding, findings of centrally read flexible proctosigmoidoscopy and PGA, each graded from 0 to 3 with higher scores indicating more severe disease. These scores were summed up to give a total score range of 0 to 12; where higher scores indicating more severe disease.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"59.9","spread":null},{"groupId":"OG001","value":"32.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Endoscopic Remission at Week 8","description":"Endoscopic remission in participants was defined by Mayo endoscopic subscore of 0. The Mayo endoscopic subscore consisted of the findings of centrally read flexible proctosigmoidoscopy, graded from 0 to 3 with higher scores indicating more severe disease.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7","spread":null},{"groupId":"OG001","value":"1.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Clinical Remission at Week 8","description":"Clinical remission in participants was defined by a total Mayo score of 2 points or lower, with no individual subscore exceeding 1 point. Mayo score is an instrument designed to measure disease activity of UC. It consisted of 4 subscores: stool frequency, rectal bleeding, findings of centrally read flexible proctosigmoidoscopy and PGA, each graded from 0 to 3 with higher scores indicating more severe disease. These scores were summed up to give a total score range of 0 to 12; where higher scores indicating more severe disease.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.5","spread":null},{"groupId":"OG001","value":"8.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Symptomatic Remission at Week 8","description":"Symptomatic remission in participants was defined by a total Mayo score of 2 points or lower, with no individual subscore exceeding 1 point, and 0 subscore for both rectal bleeding and stool frequency. Mayo score is an instrument designed to measure disease activity of UC. It consisted of 4 subscores: stool frequency, rectal bleeding, findings of centrally read flexible proctosigmoidoscopy and PGA, each graded from 0 to 3 with higher scores indicating more severe disease. These scores were summed up to give a total score range of 0 to 12; where higher scores indicating more severe disease.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11.8","spread":null},{"groupId":"OG001","value":"5.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Deep Remission at Week 8","description":"Deep remission in participants was defined by a total Mayo score of 2 points or lower, with no individual subscore exceeding 1 point and 0 subscore for both rectal bleeding and endoscopic subscores. Mayo score is an instrument designed to measure disease activity of UC. It consisted of 4 subscores: stool frequency, rectal bleeding, findings of centrally read flexible proctosigmoidoscopy and PGA, each graded from 0 to 3 with higher scores indicating more severe disease. These scores were summed up to give a total score range of 0 to 12; where higher scores indicating more severe disease.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.5","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Partial Mayo Scores","description":"A Partial Mayo Score (mayo score without endoscopy) graded from 0 (normal or inactive disease) to 9 (severe disease) and calculated as the sum of 3 subscores (stool frequency, rectal bleeding and PGA) with each grading from 0 to 3 with higher scores indicating more severe disease.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.3","spread":"1.2"},{"groupId":"OG001","value":"6.5","spread":"1.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.2","spread":"2.2"},{"groupId":"OG001","value":"5.2","spread":"2.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5","spread":"2.3"},{"groupId":"OG001","value":"4.8","spread":"2.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.2","spread":"2.4"},{"groupId":"OG001","value":"4.8","spread":"2.5"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Partial Mayo Scores at Weeks 2, 4 and 8","description":"Change in partial mayo scores at weeks 2, 4, 8 relative to baseline were reported. A Partial Mayo Score (mayo score without endoscopy) graded from 0 (normal or inactive disease) to 9 (severe disease) and calculated as the sum of 3 subscores (stool frequency, rectal bleeding and PGA) with each grading from 0 to 3 with higher scores indicating more severe disease.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.1","spread":"0.1"},{"groupId":"OG001","value":"-1.2","spread":"0.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.8","spread":"0.1"},{"groupId":"OG001","value":"-1.6","spread":"0.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.1","spread":"0.1"},{"groupId":"OG001","value":"-1.6","spread":"0.2"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Total Mayo Scores at Week 8","description":"Change in total Mayo scores at Week 8 relative to Baseline was reported. Mayo score is an instrument designed to measure disease activity of UC. It consisted of 4 subscores: stool frequency, rectal bleeding, findings of centrally read flexible proctosigmoidoscopy and PGA, each graded from 0 to 3 with higher scores indicating more severe disease. These scores were summed up to give a total score range of 0 to 12; where higher scores indicating more severe disease.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.0","spread":"1.4"},{"groupId":"OG001","value":"9.1","spread":"1.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.8","spread":"2.8"},{"groupId":"OG001","value":"-1.9","spread":"2.5"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":16,"n":476},"commonTop":["Nasopharyngitis","Headache","Nausea","Anaemia","Pyrexia"]}}}